Loading clinical trials...
Loading clinical trials...
Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy
Conditions
Interventions
Tesamorelin
Locations
1
United States
Neuroendocrine Unit and Pituitary Center, Columbia University
New York, New York, United States
Start Date
February 7, 2018
Primary Completion Date
April 30, 2025
Completion Date
April 30, 2025
Last Updated
May 13, 2025
NCT07484646
NCT07464899
NCT06717659
NCT07422987
NCT07333521
NCT07412782
Lead Sponsor
Columbia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions